Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 735

1.

Publisher's Note: Demonstration of Fuel Hot-Spot Pressure in Excess of 50 Gbar for Direct-Drive, Layered Deuterium-Tritium Implosions on OMEGA [Phys. Rev. Lett. 117, 025001 (2016)].

Regan SP, Goncharov VN, Igumenshchev IV, Sangster TC, Betti R, Bose A, Boehly TR, Bonino MJ, Campbell EM, Cao D, Collins TJ, Craxton RS, Davis AK, Delettrez JA, Edgell DH, Epstein R, Forrest CJ, Frenje JA, Froula DH, Gatu Johnson M, Glebov VY, Harding DR, Hohenberger M, Hu SX, Jacobs-Perkins D, Janezic R, Karasik M, Keck RL, Kelly JH, Kessler TJ, Knauer JP, Kosc TZ, Loucks SJ, Marozas JA, Marshall FJ, McCrory RL, McKenty PW.

Phys Rev Lett. 2016 Jul 29;117(5):059903. Epub 2016 Jul 29.

PMID:
27517797
2.
3.

Demonstration of Fuel Hot-Spot Pressure in Excess of 50 Gbar for Direct-Drive, Layered Deuterium-Tritium Implosions on OMEGA.

Regan SP, Goncharov VN, Igumenshchev IV, Sangster TC, Betti R, Bose A, Boehly TR, Bonino MJ, Campbell EM, Cao D, Collins TJ, Craxton RS, Davis AK, Delettrez JA, Edgell DH, Epstein R, Forrest CJ, Frenje JA, Froula DH, Gatu Johnson M, Glebov VY, Harding DR, Hohenberger M, Hu SX, Jacobs-Perkins D, Janezic R, Karasik M, Keck RL, Kelly JH, Kessler TJ, Knauer JP, Kosc TZ, Loucks SJ, Marozas JA, Marshall FJ, McCrory RL, McKenty PW, Meyerhofer DD, Michel DT, Myatt JF, Obenschain SP, Petrasso RD, Radha PB, Rice B, Rosenberg MJ, Schmitt AJ, Schmitt MJ, Seka W, Shmayda WT, Shoup MJ, Shvydky A, Skupsky S, Solodov AA, Stoeckl C, Theobald W, Ulreich J, Wittman MD, Woo KM, Yaakobi B, Zuegel JD.

Phys Rev Lett. 2016 Jul 8;117(2):025001. doi: 10.1103/PhysRevLett.117.025001. Epub 2016 Jul 7. Erratum in: Phys Rev Lett. 2016 Jul 29;117(5):059903.

PMID:
27447511
4.

Radiotherapy for Prostate Cancer: is it 'what you do' or 'the way that you do it'? A UK Perspective on Technique and Quality Assurance.

Mason MD, Moore R, Jones G, Lewis G, Donovan JL, Neal DE, Hamdy FC, Lane JA, Staffurth JN; ProtecT Study Group.

Clin Oncol (R Coll Radiol). 2016 Sep;28(9):e92-e100. doi: 10.1016/j.clon.2016.05.011. Epub 2016 Jul 12.

PMID:
27425582
5.

Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.

Lane A, Metcalfe C, Young GJ, Peters TJ, Blazeby J, Avery KN, Dedman D, Down L, Mason MD, Neal DE, Hamdy FC, Donovan JL; ProtecT Study group.

BJU Int. 2016 Jul 14. doi: 10.1111/bju.13582. [Epub ahead of print]

PMID:
27415448
6.

Structurally Enabled Discovery of Adenosine A2A Receptor Antagonists.

Jazayeri A, Andrews SP, Marshall FH.

Chem Rev. 2016 Jun 22. [Epub ahead of print]

PMID:
27333206
7.

Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength.

Segala E, Guo D, Cheng RK, Bortolato A, Deflorian F, Doré AS, Errey JC, Heitman LH, IJzerman AP, Marshall FH, Cooke RM.

J Med Chem. 2016 Jul 14;59(13):6470-9. doi: 10.1021/acs.jmedchem.6b00653. Epub 2016 Jul 1.

PMID:
27312113
8.

Extra-helical binding site of a glucagon receptor antagonist.

Jazayeri A, Doré AS, Lamb D, Krishnamurthy H, Southall SM, Baig AH, Bortolato A, Koglin M, Robertson NJ, Errey JC, Andrews SP, Teobald I, Brown AJ, Cooke RM, Weir M, Marshall FH.

Nature. 2016 Apr 25;533(7602):274-7. doi: 10.1038/nature17414.

PMID:
27111510
9.

Measurement of Exercise Tolerance before Surgery (METS) study: a protocol for an international multicentre prospective cohort study of cardiopulmonary exercise testing prior to major non-cardiac surgery.

Wijeysundera DN, Pearse RM, Shulman MA, Abbott TE, Torres E, Croal BL, Granton JT, Thorpe KE, Grocott MP, Farrington C, Myles PS, Cuthbertson BH; METS Study Investigators.

BMJ Open. 2016 Mar 11;6(3):e010359. doi: 10.1136/bmjopen-2015-010359. Erratum in: BMJ Open. 2016;6(4):e010359corr1.

11.

The impact of oculomotor functioning on neuropsychological performance in Huntington disease.

Carvalho JO, Long JD, Westervelt HJ, Smith MM, Bruce JM, Kim JI, Mills JA, Paulsen JS; PREDICT-HD Investigators And Coordinators Of The Huntington Study Group.

J Clin Exp Neuropsychol. 2016;38(2):217-26. doi: 10.1080/13803395.2015.1101054.

PMID:
26745770
12.

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.

Huntington Study Group PHAROS Investigators, Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, Siemers E, Tanner C, Mallonee W, Suter G, Dubinsky R, Gray C, Nance M, Bundlie S, Radtke D, Kostyk S, Baic C, Caress J, Walker F, Hunt V, O'Neill C, Chouinard S, Factor S, Greenamyre T, Wood-Siverio C, Corey-Bloom J, Song D, Peavy G, Moskowitz C, Wesson M, Samii A, Bird T, Lipe H, Blindauer K, Marshall F, Zimmerman C, Goldstein J, Rosas D, Novak P, Caviness J, Adler C, Duffy A, Wheelock V, Tempkin T, Richman D, Seeberger L, Albin R, Chou KL, Racette B, Perlmutter JS, Perlman S, Bordelon Y, Martin W, Wieler M, Leavitt B, Raymond L, Decolongon J, Clarke L, Jankovic J, Hunter C, Hauser RA, Sanchez-Ramos J, Furtado S, Suchowersky O, Klimek ML, Guttman M, Sethna R, Feigin A, Cox M, Shannon B, Percy A, Dure L, Harrison M, Johnson W, Higgins D, Molho E, Nickerson C, Evans S, Hobson D, Singer C, Galvez-Jimenez N, Shannon K, Comella C, Ross C, Saint-Hilaire MH, Testa C, Rosenblatt A, Hogarth P, Weiner W, Como P, Kumar R, Cotto C, Stout J, Brocht A, Watts A, Eberly S, Weaver C, Foroud T, Gusella J, MacDonald M, Myers R, Fahn S, Shults C.

JAMA Neurol. 2016 Jan;73(1):102-10. doi: 10.1001/jamaneurol.2015.2736.

PMID:
26569098
13.

An extremely bright gamma-ray pulsar in the Large Magellanic Cloud.

Fermi LAT Collaboration.

Science. 2015 Nov 13;350(6262):801-5. doi: 10.1126/science.aac7400.

PMID:
26564852
14.

Motor onset and diagnosis in Huntington disease using the diagnostic confidence level.

Liu D, Long JD, Zhang Y, Raymond LA, Marder K, Rosser A, McCusker EA, Mills JA, Paulsen JS; PREDICT-HD Investigators and Coordinators of the Huntington Study Group.

J Neurol. 2015 Dec;262(12):2691-8. doi: 10.1007/s00415-015-7900-7. Epub 2015 Sep 26.

PMID:
26410751
15.

Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial.

Wade J, Holding PN, Bonnington S, Rooshenas L, Lane JA, Salter CE, Tilling K, Speakman MJ, Brewster SF, Evans S, Neal DE, Hamdy FC, Donovan JL; ProtecT Study Group.

BMJ Open. 2015 Sep 18;5(9):e008953. doi: 10.1136/bmjopen-2015-008953.

16.

Selective Negative Allosteric Modulation Of Metabotropic Glutamate Receptors – A Structural Perspective of Ligands and Mutants.

Harpsøe K, Isberg V, Tehan BG, Weiss D, Arsova A, Marshall FH, Bräuner-Osborne H, Gloriam DE.

Sci Rep. 2015 Sep 11;5:13869. doi: 10.1038/srep13869.

17.

Structures of G protein-coupled receptors reveal new opportunities for drug discovery.

Cooke RM, Brown AJ, Marshall FH, Mason JS.

Drug Discov Today. 2015 Nov;20(11):1355-64. doi: 10.1016/j.drudis.2015.08.003. Epub 2015 Aug 22. Review.

PMID:
26303408
18.

Purification of Stabilized GPCRs for Structural and Biophysical Analyses.

Errey JC, Doré AS, Zhukov A, Marshall FH, Cooke RM.

Methods Mol Biol. 2015;1335:1-15. doi: 10.1007/978-1-4939-2914-6_1.

PMID:
26260590
19.

Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile).

Christopher JA, Aves SJ, Bennett KA, Doré AS, Errey JC, Jazayeri A, Marshall FH, Okrasa K, Serrano-Vega MJ, Tehan BG, Wiggin GR, Congreve M.

J Med Chem. 2015 Aug 27;58(16):6653-64. doi: 10.1021/acs.jmedchem.5b00892. Epub 2015 Aug 12.

PMID:
26225459
20.

Pharmacology and physiology of gastrointestinal enteroendocrine cells.

Mace OJ, Tehan B, Marshall F.

Pharmacol Res Perspect. 2015 Aug;3(4):e00155. doi: 10.1002/prp2.155. Epub 2015 Jul 7. Review.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk